Mediators of the effects of canagliflozin on N-terminal pro-brain natriuretic peptide concentration: An exploratory mediation analysis of the randomized CANDLE trial

Diabetes Obes Metab. 2022 May;24(5):962-965. doi: 10.1111/dom.14656. Epub 2022 Feb 21.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Canagliflozin* / adverse effects
  • Humans
  • Mediation Analysis*
  • Natriuretic Peptide, Brain
  • Peptide Fragments

Substances

  • Biomarkers
  • Peptide Fragments
  • pro-brain natriuretic peptide (1-76)
  • Canagliflozin
  • Natriuretic Peptide, Brain

Associated data

  • UMIN-CTR/UMIN000017669